Literature DB >> 33539841

COUNTERPOINT: Is It Ethically Permissible to Unilaterally Withdraw Life-Sustaining Treatments for Reallocation During Crisis Standards of Care? No.

Daniel P Sulmasy1, Fabien Maldonado2.   

Abstract

Year:  2021        PMID： 33539841     DOI： 10.1016/j.chest.2021.01.032

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  2 in total

1.  COVID-19 and Unilateral Withdrawal of Life-Sustaining Treatments: Tragedy in Crisis, and Lessons for Everyday Medicine.

Authors:  Benjamin W Frush; Jessica M Turnbull
Journal:  Chest       Date:  2021-02-10       Impact factor: 9.410

2.  D-dimer, BNP/NT-pro-BNP, and creatinine are reliable decision-making biomarkers in life-sustaining therapies withholding and withdrawing during COVID-19 outbreak.

Authors:  David M Smadja; Benjamin A Fellous; Guillaume Bonnet; Caroline Hauw-Berlemont; Willy Sutter; Agathe Beauvais; Charles Fauvel; Aurélien Philippe; Orianne Weizman; Delphine Mika; Philippe Juvin; Victor Waldmann; Jean-Luc Diehl; Ariel Cohen; Richard Chocron
Journal:  Front Cardiovasc Med       Date:  2022-09-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.